Home
›
Damora Therapeutics, Inc.
› SCHEDULE 13G/A Feb 9, 2024
Damora Therapeutics, Inc. (DMRA): SCHEDULE 13G/A filed Feb 9, 2024
Form type
SCHEDULE 13G/A
Filing date
Feb 9, 2024
Accession number
0001995601-24-000002
Filer
Damora Therapeutics, Inc.
(CIK 1800315)